scholarly journals Multi-modal treatment strategy for achieving an aesthetic lower face

2020 ◽  
Vol 47 (3) ◽  
pp. 256-262
Author(s):  
Tae Kwang Jeong ◽  
Chang Ho Chung ◽  
Kyung Hee Min
Keyword(s):  
Minimally Invasive ◽  
Botulinum Toxin Type A ◽  
Botulinum Toxin Type ◽  
Fat Grafting ◽  
Invasive Procedures ◽  
Fat Pad ◽  
Lower Face ◽  
Filler Injection ◽  
Filler Injections ◽  
Modal Treatment

Background Most women consider an oval-shaped face to be youthful and beautiful. In recent years, demand has grown for surgical procedures with a shorter downtime and fewer complications. These minimally invasive procedures include botulinum toxin type A (BoNTA) injection, filler injection, suction-assisted liposuction (SAL), laser-assisted lipolysis (LAL), thread lifting, and fat grafting. This study aims to introduce an effective method for creating an aesthetically pleasing lower face using a combination of minimally invasive procedures.Methods From March 2017 to March 2019, 94 patients simultaneously underwent LAL, SAL, and thread lifting. Ancillary procedures such as BoNTA injections, hyaluronic acid filler injections, and removal of the buccal fat pad (BFP) were selectively performed according to the patient’s condition.Results Patients rated their postoperative satisfaction as very satisfied, satisfied, dissatisfied, or very dissatisfied. Approximately 83% of all respondents were satisfied with the results, whereas the remaining respondents had complaints regarding the outcomes. The most common reasons for dissatisfaction were a longer-than-expected recovery time and undercorrection, and the most severe complaint was skin depression as a result of overcorrection.Conclusions Our method of simultaneously performing LAL, SAL, and thread lifting, while adding BoNTA, filler injections, and BFP removal as needed, was capable of producing consistent and reliable aesthetic outcomes for the lower face.

scholarly journals 452 Dermal Filler Injection Leading to Facial Cellulitis: A Case Report

2021 ◽  
Vol 108 (Supplement_6) ◽  
Author(s):  
E Baldock ◽  
C Devine ◽  
A Holden ◽  
S Colbert
Keyword(s):  
Hospital Admission ◽  
Botulinum Toxin Type A ◽  
Botulinum Toxin Type ◽  
Dermal Filler ◽  
Filler Injection ◽  
Facial Filler ◽  
Intravenous Antibiotics ◽  
Filler Injections ◽  
Aesthetic Procedure ◽  
Dermal Filler Injection

Abstract Background Aesthetic medicine is a rapidly expanding field that is progressively becoming a normal part of society’s health and beauty regime. Hyaluronic Acid dermal filler injections are the second most widely performed aesthetic procedure, following Botulinum Toxin type A. Although serious complications are rare, they can have a detrimental impact on aesthetic outcome and general health. Infections following dermal fillers can be difficult to treat and have the potential to require hospital admission, intravenous antibiotics and surgical intervention. Case description We present a case of a 41-year-old female who suffered from facial cellulitis as a consequence of palpebro-malar groove dermal filler injections. The patient had 0.1ml of Monalisa dermal filler injected over her right malar prominence and suffered complications 6 days later, which eventually lead to the need for hospital admission on day 12 following the procedure for intravenous antibiotics. The management of this aesthetic procedure complication is outlined to highlight the risks and serious complications of these procedures. Conclusions Facial cellulitis is a rare adverse event following facial filler injection; however, it is an important risk factor to discuss during the consent process for these procedures. In addition, it is important that a highly trained and skilled professional performs these injections using a sterile non-touch technique due to the potential for serious complications and the anatomical proximity to vital structures.

Can occlusal devices prolong the effect of botulinum toxin type A in the contouring of the lower face?

2009 ◽  
Vol 33 (1) ◽  
pp. 35-40 ◽  
Author(s):  
Raffaele Rauso ◽  
Mario Santagata ◽  
Giuseppe Colella ◽  
Nicola Nesi ◽  
Giulio Gherardini ◽  
...  
Keyword(s):  
Botulinum Toxin ◽  
Botulinum Toxin Type A ◽  
Type A ◽  
Botulinum Toxin Type ◽  
Lower Face

The wrinkles soothing effect on the middle and lower face by intradermal injection of botulinum toxin type A

2008 ◽  
Vol 47 (12) ◽  
pp. 1287-1294 ◽  
Author(s):  
Shao-Ping Chang ◽  
Hsiou-Hsin Tsai ◽  
Wei-Yu Chen ◽  
Woan-Ruoh Lee ◽  
Ping-Ling Chen ◽  
...  
Keyword(s):  
Botulinum Toxin ◽  
Botulinum Toxin Type A ◽  
Type A ◽  
Botulinum Toxin Type ◽  
Intradermal Injection ◽  
Lower Face

scholarly journals Botulinum Toxin (Type A) as a Minimally Invasive Treatment for Gengival Smile: Case Report

2020 ◽  
Vol 1 (1) ◽  
Author(s):  
Broilo Kethylin ◽  
Ramalho Juliana Alves da Silva ◽  
Pereira Priscilla Aparecida ◽  
Ramalho Karen Muller ◽  
Morimoto Susana
Keyword(s):  
Case Report ◽  
Botulinum Toxin ◽  
Minimally Invasive ◽  
Botulinum Toxin Type A ◽  
Type A ◽  
Botulinum Toxin Type ◽  
Minimally Invasive Treatment ◽  
Invasive Treatment

Botulinum Toxin Type A Treatment for Contouring of the Lower Face

2003 ◽  
Vol 29 (5) ◽  
pp. 477-483 ◽  
Author(s):  
Mee Young Park ◽  
Ki Young Ahn ◽  
Duck Soo Jung
Keyword(s):  
Botulinum Toxin ◽  
Botulinum Toxin Type A ◽  
Type A ◽  
Botulinum Toxin Type ◽  
Lower Face

Effects of Botulinum Toxin Type A on Contouring of the Lower Face

2005 ◽  
Vol 31 (5) ◽  
pp. 502-508 ◽  
Author(s):  
SEONG WOOK CHOE ◽  
WAN IK CHO ◽  
CHANG KYUN LEE ◽  
SEONG JUN SEO
Keyword(s):  
Botulinum Toxin ◽  
Botulinum Toxin Type A ◽  
Type A ◽  
Botulinum Toxin Type ◽  
Lower Face

Effects of Botulinum Toxin Type A on Contouring of the Lower Face

2006 ◽  
Vol 31 (5) ◽  
pp. 502-508 ◽  
Author(s):  
Seong Wook Choe ◽  
Wan Ik Cho ◽  
Chang Kyun Lee ◽  
Seong Jun Seo
Keyword(s):  
Botulinum Toxin ◽  
Botulinum Toxin Type A ◽  
Type A ◽  
Botulinum Toxin Type ◽  
Lower Face

scholarly journals Botulinum toxin in the treatment of gummy smile

2020 ◽  
Vol 3 (2) ◽  
pp. 133-138
Author(s):  
Marcelina Muszalska ◽  
Patrycja Przybylska ◽  
Michał Piwowarek ◽  
Oskar Komisarek ◽  
Teresa Matthews‑Brzozowska
Keyword(s):  
Botulinum Toxin ◽  
Minimally Invasive ◽  
Muscle Activity ◽  
Botulinum Toxin Type A ◽  
Botulinum Toxin Type ◽  
Skeletal Defect ◽  
Gender And Age ◽  
Invasive Method ◽  
The Right ◽  
Gummy Smile

A gummy smile is an excessive exposure of the gums while smiling. There are four types: anterior- excessive gum exposure from canine to canine, posterior — excessive gum exposure in the lateral segment, mixed — combining the anterior and posterior components, and asymmetrical — with a disproportion between the right and left side. The causes of gingival smile include: skeletal defect, delayed passive tooth eruption, nasal septal dysplasia, and excessive muscle activity. A simple, fast and minimally invasive method of gummy smile therapy caused by excessive muscle activity is the supply of botulinum toxin type A to the muscles responsible for a given type of smile. A favorable aesthetic effect can be achieved with a good knowledge of application sites and individually selected doses. When determining the dose, which is described in the literature between 2 IU and 10 IU onabotulin per page, researchers take into account not only the type of corrected smile, the number of puncture points, but also gender and age of the patient.

Sign in / Sign up

Export Citation Format

Share Document